SR Medical Technology Company Limited (HKG:0108)
Hong Kong · Delayed Price · Currency is HKD 2.035
-0.225 (-9.96%)
Sep 10, 2026, 4:08 PM HKT
HKG:0108 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property Management Fees | 380.33 | 327.91 | 310.02 | 352.64 | 352.28 | 331.34 |
| 380.33 | 327.91 | 310.02 | 352.64 | 352.28 | 331.34 | |
Revenue Growth (YoY | 25.72% | 5.77% | -12.09% | 0.10% | 6.32% | 9.88% |
Property Expenses | 131.5 | 118.93 | 111.47 | 108.98 | 122.46 | 145.93 |
Selling, General & Administrative | - | - | - | - | - | 0.84 |
Depreciation & Amortization | 6.89 | 1.46 | 2.28 | 2.54 | 3.21 | 3.96 |
Other Operating Expenses | 233.01 | 150.19 | 121.56 | 94.35 | 93.01 | 148.91 |
Total Operating Expenses | 364.2 | 262.73 | 235.68 | 212.77 | 226.8 | 312.12 |
Operating Income | 16.13 | 65.18 | 74.34 | 139.87 | 125.48 | 19.22 |
Interest Expense | -182.93 | -153.63 | -143.11 | -129.11 | -136.45 | -108.09 |
Interest & Investment Income | 3.41 | 5.76 | 13.1 | 7.63 | 4.74 | 5.06 |
Currency Exchange Gain (Loss) | 0.38 | 0.38 | - | 5.45 | - | 2.08 |
Other Non-Operating Income | 0.42 | 0.42 | -0.71 | 28.92 | 12.92 | - |
EBT Excluding Unusual Items | -162.6 | -81.89 | -56.38 | 52.76 | 6.69 | -81.74 |
Gain (Loss) on Sale of Assets | - | - | - | - | 3.81 | - |
Asset Writedown | -48.06 | -55.68 | -930.73 | -122.71 | -344.78 | 214.87 |
Other Unusual Items | 1.87 | 1.87 | 19.6 | - | - | - |
Pretax Income | -208.78 | -135.7 | -967.51 | -69.95 | -334.28 | 133.13 |
Income Tax Expense | -28.74 | -25.68 | -48.16 | 59.36 | -14.15 | 56.88 |
Earnings From Continuing Operations | -180.04 | -110.02 | -919.34 | -129.31 | -320.13 | 76.25 |
Earnings From Discontinued Operations | - | - | - | - | - | 132.18 |
Net Income to Company | -180.04 | -110.02 | -919.34 | -129.31 | -320.13 | 208.43 |
Minority Interest in Earnings | -2.29 | 0.39 | 0.84 | - | - | -0.8 |
Net Income | -182.33 | -109.63 | -918.5 | -129.31 | -320.13 | 207.63 |
Net Income to Common | -182.33 | -109.63 | -918.5 | -129.31 | -320.13 | 207.63 |
Net Income Growth | - | - | - | - | - | 37513.22% |
Basic Shares Outstanding | 3,216 | 3,216 | 3,219 | 3,199 | 3,199 | 3,199 |
Diluted Shares Outstanding | 3,216 | 3,216 | 3,219 | 3,199 | 3,199 | 4,564 |
Shares Change | 0.31% | -0.09% | 0.63% | - | -29.89% | 42.64% |
EPS (Basic) | -0.06 | -0.03 | -0.29 | -0.04 | -0.10 | 0.06 |
EPS (Diluted) | -0.06 | -0.03 | -0.29 | -0.04 | -0.10 | 0.05 |
EPS Growth | - | - | - | - | - | 26513.95% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Margin | 4.24% | 19.88% | 23.98% | 39.66% | 35.62% | 5.80% |
Profit Margin | -47.94% | -33.43% | -296.27% | -36.67% | -90.87% | 62.66% |
EBITDA | 16.49 | 65.53 | 74.95 | 140.75 | 126.42 | 21.66 |
EBITDA Margin | 4.33% | 19.98% | 24.18% | 39.91% | 35.88% | 6.54% |
D&A For Ebitda | 0.36 | 0.35 | 0.61 | 0.88 | 0.94 | 2.44 |
EBIT | 16.13 | 65.18 | 74.34 | 139.87 | 125.48 | 19.22 |
EBIT Margin | 4.24% | 19.88% | 23.98% | 39.66% | 35.62% | 5.80% |
Effective Tax Rate | - | - | - | - | - | 42.73% |